Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.257
-0.021 (-7.62%)
Apr 29, 2026, 9:56 AM EDT - Market open
Mereo BioPharma Group Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -41.88 | -43.25 | -29.47 | -42.22 | 17.23 | |
| Depreciation & Amortization | 1.15 | 1.09 | 1.06 | 0.89 | 0.87 | |
| Loss (Gain) From Sale of Assets | - | - | - | - | -0.15 | |
| Stock-Based Compensation | 7.6 | 7.39 | 4.92 | 4.77 | 4.47 | |
| Other Operating Activities | 5.36 | 2.31 | 3.94 | -9.91 | -27.01 | |
| Change in Accounts Receivable | - | - | - | - | -0.8 | |
| Change in Accounts Payable | -1.38 | 0.15 | -1.26 | 0.62 | -1.7 | |
| Change in Other Net Operating Assets | -1.83 | -0.52 | -0.33 | -2.97 | - | |
| Operating Cash Flow | -30.97 | -32.83 | -21.13 | -48.82 | -7.09 | |
| Capital Expenditures | -0.02 | - | - | -0.01 | -0.72 | |
| Sale (Purchase) of Intangibles | - | -0.7 | -0.42 | 2 | 0.15 | |
| Other Investing Activities | - | - | - | - | 0 | |
| Investing Cash Flow | -0.02 | -0.7 | -0.42 | 1.99 | -0.57 | |
| Long-Term Debt Repaid | - | - | -3.19 | - | -0.94 | |
| Net Debt Issued (Repaid) | - | - | -3.19 | - | -0.94 | |
| Issuance of Common Stock | 0.53 | 47 | 11.61 | - | 106.4 | |
| Other Financing Activities | -0.2 | -0.85 | -0.44 | 0.2 | -0.32 | |
| Financing Cash Flow | 0.33 | 46.15 | 7.97 | 0.2 | 105.15 | |
| Foreign Exchange Rate Adjustments | 1.85 | -0.23 | 2.82 | -12.58 | -1.58 | |
| Miscellaneous Cash Flow Adjustments | - | - | -0 | - | - | |
| Net Cash Flow | -28.81 | 12.38 | -10.76 | -59.22 | 95.9 | |
| Free Cash Flow | -30.99 | -32.83 | -21.13 | -48.83 | -7.82 | |
| Free Cash Flow Margin | -6198.20% | - | -211.32% | - | -15.83% | |
| Free Cash Flow Per Share | -0.19 | -0.22 | -0.16 | -0.41 | -0.07 | |
| Cash Interest Paid | 0.03 | 0.02 | 0.88 | 0.02 | - | |
| Cash Income Tax Paid | - | - | -1.34 | 1.88 | - | |
| Levered Free Cash Flow | -18.1 | -21.5 | -14.17 | -32.74 | -9.08 | |
| Unlevered Free Cash Flow | -17.94 | -20.64 | -12.37 | -30.13 | -5.88 | |
| Change in Working Capital | -3.2 | -0.37 | -1.59 | -2.35 | -2.5 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.